Lifeon Pharmaceutical: Methylphenidate Hydrochloride Extended-Release Tablets are expected to be launched by the end of the third quarter of this year

Lifeon Pharmaceutical stated on the Shenzhen Stock Exchange interactive platform that methylphenidate hydrochloride sustained-release tablets are expected to be launched by the end of the third quarter of this year. During the period between approval and launch, a relatively complete commercialization plan and preparations will be made, and work such as market access, hospital admission, and professional promotion will be implemented as planned. Methylphenidate hydrochloride sustained-release tablets utilize advanced three-layer osmotic pump controlled-release technology to achieve rapid onset through precise controlled release, effectively maintaining stable efficacy throughout the day, consistent with the "Focus Da" formulation technology